The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Comparability : Manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14-15 September 2015

På svenska

Author

  • David J. Williams
  • Richard Archer
  • Peter Archibald
  • Ioannis Bantounas
  • Ricardo Baptista
  • Roger Barker
  • Jacqueline Barry
  • Florence Bietrix
  • Nicholas Blair
  • Julian Braybrook
  • Jonathan Campbell
  • Maurice Canham
  • Amit Chandra
  • Gabor Foldes
  • Rudy Gilmanshin
  • Mathilde Girard
  • Erwin Gorjup
  • Zöe Hewitt
  • Paul Hourd
  • Johan Hyllner
  • Helen Jesson
  • Jasmin Kee
  • Julie Kerby
  • Nina Kotsopoulou
  • Stanley Kowalski
  • Chris Leidel
  • Damian Marshall
  • Louis Masi
  • Mark McCall
  • Conor McCann
  • Nicholas Medcalf
  • Harry Moore
  • Hiroki Ozawa
  • David Pan
  • Malin Parmar
  • Anne L. Plant
  • Yvonne Reinwald
  • Sujith Sebastian
  • Glyn Stacey
  • Robert J. Thomas
  • Dave Thomas
  • Jamie Thurman-Newell
  • Marc Turner
  • Loriana Vitillio
  • Ivan Wall
  • Alison Wilson
  • Jacqueline Wolfrum
  • Ying Yang
  • Heiko Zimmerman
Show all

Summary, in English

This paper summarizes the proceedings of a workshop held at Trinity Hall, Cambridge to discuss comparability and includes additional information and references to related information added subsequently to the workshop. Comparability is the need to demonstrate equivalence of product after a process change; a recent publication states that this 'may be difficult for cell-based medicinal products'. Therefore a well-managed change process is required which needs access to good science and regulatory advice and developers are encouraged to seek help early. The workshop shared current thinking and best practice and allowed the definition of key research questions. The intent of this report is to summarize the key issues and the consensus reached on each of these by the expert delegates.

Publishing year

2016-07-01

Language

English

Pages

483-492

Publication/Series

Regenerative Medicine

Volume

11

Issue

5

Document type

Journal article

Publisher

Future Medicine Ltd.

Topic

  • Neurosciences

Keywords

  • Advice
  • Comparability
  • Human pluripotent stem cell derived
  • Manufacturing
  • Quality
  • Regulatory

Status

Published

Research group

  • Developmental and Regenerative Neurobiology

ISBN/ISSN/Other

  • ISSN: 1746-0751